Mimi Healy, PhD
President and CEO, Bacterial Barcodes, Inc.

Mimi Healy received her Ph.D. from Washington State University in Microbiology.  She has been employed by Innogenetics, a Belgium based biotechnology company as a Product Manager and Visible Genetics, a diagnostics company that manufactured and distributed sequenced-based diagnostic systems for genotyping, specifically, she managed the Hepatitis Program.  She joined Bacterial Barcodes, Inc., which develops, manufactures, and distributes the DiversiLab System: automated rep-PCR for microbial typing, in 2002 as the CSO and is currently the president and CEO.